Telsey Advisory Group Issues Pessimistic Forecast for Vital Farms (NASDAQ:VITL) Stock Price

Vital Farms (NASDAQ:VITL) had its price objective lowered by research analysts at Telsey Advisory Group from $35.00 to $26.00 in a research note issued on Friday, Marketbeat reports. The brokerage presently has an “outperform” rating on the stock. Telsey Advisory Group’s price objective points to a potential upside of 97.87% from the company’s current price.

Several other research firms have also recently commented on VITL. Benchmark cut Vital Farms from a “buy” rating to a “hold” rating in a report on Thursday, February 26th. Mizuho dropped their price objective on Vital Farms from $48.00 to $40.00 and set an “outperform” rating on the stock in a report on Monday, March 2nd. Needham & Company LLC cut their price objective on Vital Farms from $45.00 to $35.00 and set a “buy” rating for the company in a research report on Monday, March 2nd. Morgan Stanley reiterated an “equal weight” rating and issued a $24.00 price objective (down from $45.00) on shares of Vital Farms in a research report on Friday, February 27th. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Vital Farms in a report on Monday, December 29th. Nine research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $42.82.

Vital Farms Stock Performance

Shares of VITL opened at $13.14 on Friday. The stock has a market capitalization of $588.67 million, a P/E ratio of 9.13 and a beta of 1.14. The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.61 and a current ratio of 2.16. Vital Farms has a 1 year low of $12.80 and a 1 year high of $53.13. The company’s fifty day moving average is $22.83 and its two-hundred day moving average is $31.40.

Vital Farms (NASDAQ:VITL) last released its earnings results on Thursday, February 26th. The company reported $0.35 EPS for the quarter, missing the consensus estimate of $0.38 by ($0.03). Vital Farms had a return on equity of 20.69% and a net margin of 8.73%.The firm had revenue of $213.55 million during the quarter, compared to analyst estimates of $212.83 million. During the same quarter last year, the business posted $0.23 EPS. The firm’s revenue was up 28.6% on a year-over-year basis. On average, sell-side analysts predict that Vital Farms will post 1.11 earnings per share for the current year.

Insider Buying and Selling at Vital Farms

In related news, Director Karl Khoury acquired 5,000 shares of the company’s stock in a transaction that occurred on Monday, March 9th. The stock was purchased at an average price of $18.45 per share, for a total transaction of $92,250.00. Following the transaction, the director owned 119,789 shares in the company, valued at $2,210,107.05. This trade represents a 4.36% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Matthew Ohayer sold 25,000 shares of the company’s stock in a transaction that occurred on Friday, January 2nd. The stock was sold at an average price of $30.85, for a total transaction of $771,250.00. Following the transaction, the insider directly owned 6,361,190 shares of the company’s stock, valued at $196,242,711.50. This trade represents a 0.39% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 65,000 shares of company stock valued at $1,736,050 in the last three months. 21.30% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the stock. Royal Bank of Canada lifted its position in shares of Vital Farms by 89.2% during the first quarter. Royal Bank of Canada now owns 19,381 shares of the company’s stock worth $591,000 after purchasing an additional 9,136 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in Vital Farms by 5.8% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 20,057 shares of the company’s stock worth $611,000 after buying an additional 1,108 shares during the period. Goldman Sachs Group Inc. increased its stake in Vital Farms by 3.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 415,420 shares of the company’s stock worth $12,658,000 after buying an additional 13,397 shares during the period. Woodline Partners LP acquired a new position in Vital Farms in the 1st quarter worth $1,073,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in Vital Farms by 1.4% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 89,893 shares of the company’s stock worth $2,739,000 after buying an additional 1,198 shares in the last quarter. Institutional investors and hedge funds own 98.59% of the company’s stock.

Key Vital Farms News

Here are the key news stories impacting Vital Farms this week:

• Positive Sentiment: Two sell‑side firms cut price targets but kept bullish ratings (Needham lowered its target to $20 with a “buy”; Telsey cut its target to $26 with an “outperform”), signaling continued analyst conviction that there is upside from current levels. Benzinga note on price target changes
• Neutral Sentiment: Balance‑sheet and valuation context: VITL trades at a low P/E (~9x) with minimal debt (debt/equity ~0.01), which can support recovery if operational trends improve. (Background market data)
• Negative Sentiment: Multiple securities class‑action filings and investor notices were announced this week (Rosen Law Firm, Robbins LLP and related alerts), alleging Vital Farms made materially misleading statements and seeking damages for purchases from May 8, 2025 through Feb 26, 2026; Rosen’s notice sets a lead‑plaintiff motion deadline of May 26, 2026 — a clear near‑term legal overhang. Rosen Law Firm filing Business Wire Rosen alert Robbins LLP notice
• Negative Sentiment: Recent price action shows notable weakness (a larger drop was reported on 3/26), underscoring market sensitivity to the legal headlines and recent operating/earnings signals. Zacks price‑action note

About Vital Farms

Vital Farms, traded on the NASDAQ under the symbol VITL, is a U.S.-based food company specializing in pasture-raised egg and dairy products. The company partners with a network of family farms across the United States to produce eggs, butter and related items under a certified humane, pasture-centric farming model. Vital Farms’ supply chain emphasizes animal welfare, environmental stewardship and transparent sourcing, appealing to consumers seeking ethically produced, high-quality ingredients.

Founded in 2007 and headquartered in Austin, Texas, Vital Farms began by marketing pasture-raised eggs to health- and ethically minded shoppers.